ArticleEthiopian journal of health sciences2023
Frequency of Developing COVID-19 Pneumonia in Patients Who Were Vaccinated Double-Dose CoronaVac: Data of the Pandemic Authorized Hospital in Northern Cyprus.
Article in Ethiopian journal of health sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: RT-PCR is the leading method used in the diagnosis of COVID-19, caused by 2019-nCoV. CT applications also provide a fast and easy diagnosis for detecting pneumonia caused by the SARS-CoV-2 virus. The current study, aimed to compare the lung involvement of vaccinated (two-dose CoronaVac) and unvaccinated patients in the early stage of COVID-19 disease. Methods: In the current retrospective study, which included patients diagnosed with RT-PCR COVID-19 positivity (n=651) between 01 July 2021-15 September 2021, patient information was obtained from the authorized hospital of the pandemic. Data included patients' chest CT scans and whether patients had been vaccinated (two-dose CoronaVac) information. Results: The ratio of vaccination with double-dose CoronaVac in positive patients was 74.3%. The ratio of patients with normal lung appearance was 61.8%. It was determined that the ratio of involvement in both lungs of patients who were vaccinated with a double dose was significantly lower than the ratio of involvement in patients who were never vaccinated (p <0.001). Conclusion: In this study, it was determined that pneumonia cases were less common in individuals vaccinated with double-dose CoronaVac. In this study, it was also determined that the protection of the vaccine was higher in females than in males and that the protection of the double-dose CoronaVac vaccine was higher in the 50-60 age group compared to 60 older patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.